- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 24,158,062
- Share change
- +3,074,357
- Total reported value
- $1,210,838,699
- Put/Call ratio
- 254%
- Price per share
- $50.12
- Number of holders
- 150
- Value change
- +$158,389,093
- Number of buys
- 84
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Pentwater Capital Management LP |
13F
|
Company |
0.77%
|
1,988,000
|
$92,005,000 | — | 30 Jun 2017 | |
| BB BIOTECH AG |
13F
|
Company |
0.59%
|
1,513,542
|
$70,047,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.58%
|
1,506,514
|
$69,721,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
0.52%
|
1,338,588
|
$61,950,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.49%
|
1,278,206
|
$59,154,000 | — | 30 Jun 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.43%
|
1,113,793
|
$51,546,000 | — | 30 Jun 2017 | |
| Boxer Capital, LLC |
13F
|
Company |
0.39%
|
1,000,000
|
$46,280,000 | — | 30 Jun 2017 | |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT |
13F
|
Company |
0.37%
|
965,059
|
$44,663,000 | — | 30 Jun 2017 | |
| Aisling Capital LLC |
13F
|
Company |
0.32%
|
837,125
|
$38,742,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.29%
|
756,224
|
$34,997,000 | — | 30 Jun 2017 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.29%
|
755,715
|
$34,974,000 | — | 30 Jun 2017 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.28%
|
734,453
|
$33,990,000 | — | 30 Jun 2017 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.28%
|
731,531
|
$33,855,000 | — | 30 Jun 2017 | |
| Meditor Group Ltd |
13F
|
Company |
0.22%
|
566,000
|
$26,194,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
434,913
|
$20,128,000 | — | 30 Jun 2017 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.14%
|
363,347
|
$16,816,000 | — | 30 Jun 2017 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.12%
|
318,667
|
$14,748,000 | — | 30 Jun 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.11%
|
292,917
|
$13,556,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
249,611
|
$11,552,000 | — | 30 Jun 2017 | |
| GAM Holding AG |
13F
|
Company |
0.09%
|
225,000
|
$10,413,000 | — | 30 Jun 2017 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.08%
|
213,980
|
$9,903,000 | — | 30 Jun 2017 | |
| PAULSON & CO. INC. |
13F
|
Company |
0.08%
|
210,500
|
$9,742,000 | — | 30 Jun 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.08%
|
200,483
|
$9,278,000 | — | 30 Jun 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.11%
|
272,881
|
$8,738,000 | — | 30 Jun 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
168,800
|
$7,812,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
167,872
|
$7,768,000 | — | 30 Jun 2017 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
152,061
|
$7,038,000 | — | 30 Jun 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.06%
|
142,483
|
$6,594,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
141,875
|
$6,565,000 | — | 30 Jun 2017 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.05%
|
138,977
|
$6,432,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
114,853
|
$5,315,000 | — | 30 Jun 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
108,673
|
$5,029,000 | — | 30 Jun 2017 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
101,319
|
$4,689,000 | — | 30 Jun 2017 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.04%
|
100,170
|
$4,636,000 | — | 30 Jun 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.04%
|
100,000
|
$4,628,000 | — | 30 Jun 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
81,547
|
$3,774,000 | — | 30 Jun 2017 | |
| Quantitative Investment Management, LLC |
13F
|
Company |
0.03%
|
80,800
|
$3,739,000 | — | 30 Jun 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
77,706
|
$3,597,000 | — | 30 Jun 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.03%
|
70,000
|
$3,240,000 | — | 30 Jun 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
69,877
|
$3,234,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
68,275
|
$3,160,000 | — | 30 Jun 2017 | |
| BAILARD, INC. |
13F
|
Company |
0.02%
|
63,300
|
$2,930,000 | — | 30 Jun 2017 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
57,355
|
$2,655,000 | — | 30 Jun 2017 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.02%
|
55,460
|
$2,566,000 | — | 30 Jun 2017 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.02%
|
51,667
|
$2,392,000 | — | 30 Jun 2017 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
50,148
|
$2,321,000 | — | 30 Jun 2017 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.02%
|
49,299
|
$2,282,000 | — | 30 Jun 2017 | |
| EMORY UNIVERSITY |
13F
|
Company |
0.02%
|
46,766
|
$2,164,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
44,341
|
$2,052,000 | — | 30 Jun 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
41,900
|
$1,939,000 | — | 30 Jun 2017 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q3 2017
As of 30 Sep 2017,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,158,062 shares.
The largest 10 holders included
Meditor Group Ltd, Pentwater Capital Management LP, BB BIOTECH AG, BlackRock Inc., FMR LLC, STATE STREET CORP, CREDIT SUISSE AG/, VANGUARD GROUP INC, Aisling Capital LLC, and DISCOVERY CAPITAL MANAGEMENT, LLC / CT.
This page lists
150
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
129
Q3 2017 holders
150
Holder diff
21
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.